These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 1312871)

  • 1. Purification and structural properties of two distinct TNF receptors on human cells.
    Loetscher H
    Immunol Ser; 1992; 56():161-87. PubMed ID: 1312871
    [No Abstract]   [Full Text] [Related]  

  • 2. Characterization of receptors for recombinant human tumor necrosis factor-alpha from human placental membranes.
    Aiyer RA; Aggarwal BB
    Lymphokine Res; 1990; 9(3):333-44. PubMed ID: 2169011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the receptor for tumor necrosis factor (TNF) and lymphotoxin (LT) on human T lymphocytes. TNF and LT differ in their receptor binding properties and the induction of MHC class I proteins on a human CD4+ T cell hybridoma.
    Andrews JS; Berger AE; Ware CF
    J Immunol; 1990 Apr; 144(7):2582-91. PubMed ID: 1969453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cloning and characteristics of the human genome locus containing genes of a second type of receptor (75 kDa) for tumor necrosis factor and lymphotoxin].
    Turetskaia RL; Udalova IA; Kuprash DV; Terskikh AV; Nedospasov SA
    Dokl Akad Nauk SSSR; 1991; 320(5):1258-61. PubMed ID: 1666995
    [No Abstract]   [Full Text] [Related]  

  • 5. Down-modulation of cell surface expression of p80 form of the tumor necrosis factor receptor by human immunodeficiency virus-1 tat gene.
    Pocsik E; Higuchi M; Aggarwal BB
    Lymphokine Cytokine Res; 1992 Dec; 11(6):317-25. PubMed ID: 1335762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on the differing effects of tumor necrosis factor and lymphotoxin on the growth of several human tumor lines.
    Browning J; Ribolini A
    J Immunol; 1989 Sep; 143(6):1859-67. PubMed ID: 2550545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in the biological activity of TNF alpha and TNF beta correlate with their different abilities for binding to the target cells.
    Kircheis R; Milleck J; Korobko VG; Shingarova LN; Schmidt HE
    Eur Cytokine Netw; 1992; 3(4):381-90. PubMed ID: 1330049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of 55- and 75-kDa tumor necrosis factor membrane receptors in the regulation of intercellular adhesion molecules-1 expression by HL-60 human promyelocytic leukemia cells in vitro.
    Abe Y; Gatanaga M; Osuka Y; Kimura S; Burger RA; Granger GA; Gatanaga T
    J Immunol; 1993 Jun; 150(11):5070-9. PubMed ID: 8098725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of lymphokine-activated T killer cell tumor necrosis factor receptor mRNA transcription, tumor necrosis factor receptor membrane expression, and tumor necrosis factor/lymphotoxin release by IL-1 beta, IL-4, and IL-6 in vitro.
    Dett CA; Gatanaga M; Ininns EK; Cappuccini F; Yamamoto RS; Granger GA; Gatanaga T
    J Immunol; 1991 Mar; 146(5):1522-6. PubMed ID: 1847164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crystallization and preliminary crystallographic analysis of a TNF-beta-55 kDa TNF receptor complex.
    D'Arcy A; Banner DW; Janes W; Winkler FK; Loetscher H; Schönfeld HJ; Zulauf M; Gentz R; Lesslauer W
    J Mol Biol; 1993 Jan; 229(2):555-7. PubMed ID: 8381494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blocking factors (soluble membrane receptors) for tumor necrosis factor and lymphotoxin detected in ascites and released in short-term cultures obtained from ascites and solid tumors in women with gynecologic malignancy.
    Grosen EA; Yamamoto RS; Ioli G; Ininns EK; Gatanaga M; Gatanaga T; DiSaia PJ; Berman M; Manetta A; Granger GA
    Lymphokine Cytokine Res; 1992 Dec; 11(6):347-53. PubMed ID: 1335764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coexpression of the human TNF receptors TR60 and TR80 in insect cells: analysis of receptor complex formation.
    Moosmayer D; Dinkel A; Gerlach E; Hessabi B; Grell M; Pfizenmaier K; Scheurich P
    Lymphokine Cytokine Res; 1994 Oct; 13(5):295-301. PubMed ID: 7858062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Death-inducing tumour necrosis factor (TNF) superfamily ligands and receptors are transcribed in human placentae, cytotrophoblasts, placental macrophages and placental cell lines.
    Phillips TA; Ni J; Hunt JS
    Placenta; 2001; 22(8-9):663-72. PubMed ID: 11597186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Signaling through the lymphotoxin-beta receptor stimulates HIV-1 replication alone and in cooperation with soluble or membrane-bound TNF-alpha.
    Marshall WL; Brinkman BM; Ambrose CM; Pesavento PA; Uglialoro AM; Teng E; Finberg RW; Browning JL; Goldfeld AE
    J Immunol; 1999 May; 162(10):6016-23. PubMed ID: 10229841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional comparisons of different tumour necrosis factor receptor/IgG fusion proteins.
    Scallon BJ; Trinh H; Nedelman M; Brennan FM; Feldmann M; Ghrayeb J
    Cytokine; 1995 Nov; 7(8):759-70. PubMed ID: 8664442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The TNF-TNF receptor system.
    Hehlgans T; Männel DN
    Biol Chem; 2002 Oct; 383(10):1581-5. PubMed ID: 12452434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of surface lymphotoxin forms. Use of specific monoclonal antibodies and soluble receptors.
    Browning JL; Dougas I; Ngam-ek A; Bourdon PR; Ehrenfels BN; Miatkowski K; Zafari M; Yampaglia AM; Lawton P; Meier W
    J Immunol; 1995 Jan; 154(1):33-46. PubMed ID: 7995952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding of tumor necrosis factor alpha (TNF-alpha) to high-affinity receptors on polymorphonuclear cells.
    Pichyangkul S; Schick D; Jia FL; Berent S; Bollon A; Kahn A
    Exp Hematol; 1987 Nov; 15(10):1055-9. PubMed ID: 2822458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measurement of the soluble membrane receptors for tumor necrosis factor and lymphotoxin in the sera of patients with gynecologic malignancy.
    Grosen EA; Granger GA; Gatanaga M; Ininns EK; Hwang C; DiSaia P; Berman M; Manetta A; Emma D; Gatanaga T
    Gynecol Oncol; 1993 Jul; 50(1):68-77. PubMed ID: 8394276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of differentially glycosylated forms of the soluble p75 tumor necrosis factor (TNF) receptor in human urine.
    Corti A; D'Ambrosio F; Marino M; Merli S; Cassani G
    Eur Cytokine Netw; 1995; 6(1):29-35. PubMed ID: 7795172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.